About Biodefense

Biodefense is the use of medical measures to protect people against bioterrorism. It mainly applies to two different target populations, namely military combatant (troops in the field) and civilian non-combatant. The protection of food supplies and water are often considered a critical part of biodefense. Owing to the increasing threat of terrorism and bioterrorism, the risk posed by exposure to biological agents that can be used as biological weapons must be evaluated. Biological agents used in warfare may prove to be more potent than conventional weapons. In the last century, the developments made in biochemistry and biotechnology have simplified the production of such weapons. Genetic engineering can be used to create new pathogens by manipulating genes, thereby giving rise to a whole new generation of genetically modified bioweapons. Factors such as ease of production, availability of technical know-how, and the extensive accessibility of biological agents have further led to the threat of biological weapons.

Technavio’s analysts forecast the global biodefense market to grow at a CAGR of 5.41% during the period 2017-2021.


Covered in this Report
The report covers the present scenario and the growth prospects of the global biodefense market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biodefense.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA



Technavio’s report, Global Biodefense market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Vendors

  • Altimmune
  • Bavarian Nordic
  • DynPort Vaccine Company (DVC)
  • Emergent BioSolutions




Other Prominent Vendors

  • Acambis
  • Achaogen
  • Cleveland BioLabs
  • Elusys Therapeutics




Market Driver

  • Growing threat of bioterrorism
  • For a full, detailed list, view our report




Market Challenge

  • Lack of information about bioengineered organisms attack
  • For a full, detailed list, view our report




Market Trend

  • Government initiatives
  • For a full, detailed list, view our report




Key Questions Answered in this Report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?




You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Methodology
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.